Budi Gunadi Sadikin

Minister of Health, Republic of Indonesia

Budi Gunadi Sadikin was appointed as the Health Minister in 2020. His leadership has been characterised by clear vision, swift action, and inclusive collaboration to confront some of the toughest challenges of the time. 

One of Minister Sadikin's remarkable achievements to date lies in his transformation of childhood immunisation. Despite the pandemic's disruptions, he successfully reduced the number of zero-dose children, propelling Indonesia from a ranking of third to seventh among countries with high zero-dose child populations. 

Minister Sadikin's accomplishments extend beyond crisis management. His commitment to equitable access to healthcare is evident in his efforts to increase vaccine coverage and acceptance. Under his guidance, Indonesia rolled out critical new vaccines, including the pneumococcal conjugate vaccine (PCV), human papillomavirus vaccine (HPV), and rotavirus vaccine. 

Beyond national achievements, during the G20 Presidency of Indonesia in 2022, Minister Sadikin and Sri Mulyani Indrawati, Minister of Finance, paved the way for the launching of the Pandemic Fund, signifying a stronger global commitment to pandemic prevention, preparedness, and response. 

With a nuclear physics background from the prestigious Bandung Institute of Technology, Minister Sadikin has adapted and excelled across diverse roles, including as an IT Officer at IBM, the Regional Manager of Bank Bali during the tumultuous Asian economic crisis, the CEO of Bank Mandiri, the Vice Minister of State-owned Enterprises, and now as the Minister of Health. He has undertaken prestigious executive training at Wharton University of Pennsylvania, Harvard Business School, University of California Berkeley, Stanford Graduate School of Business, and INSEAD.